Skip to main content

Newsroom press releases

17/12/24 - 12:56

2025 Annual Calendar of Corporate Events (104.79 KB)
Download

11/11/24 - 7:38

Diasorin Announces 510(k) Submission for LIAISON PLEX® Gram-Positive Blood Culture Assay, to complete the Blood Culture portfolio on LIAISON PLEX® (122.52 KB)
Products Molecular
Download

05/11/24 - 16:27

Diasorin reports another quarter with Revenues and Profitability in expansion, raising the Full-Year 2024 Revenue Guidance (238.01 KB)
Financial Data
Download

27/09/24 - 7:35

Diasorin announces 510(k) submission for LIAISON PLEX® Gram-Negative Blood Culture Assay (559.45 KB)
Products Molecular
Download

09/09/24 - 13:11

Diasorin launches the LIAISON® Streptococcus pneumoniae Ag Assay in all countries accepting the CE Mark (498.13 KB)
Products Immunodiagnostic
Download

05/09/24 - 11:17

DiaSorin S.p.A. - Update 2024 Annual Calendar of Corporate Events (99.93 KB)
Other
Download

04/09/24 - 11:36

Diasorin S.p.A. - Shareholders' Meeting September 4, 2024 (136.09 KB)
Other
Download

29/07/24 - 15:55

DIASORIN RAISES FULL-YEAR 2024 GUIDANCE AS A RESULT OF THE POSITIVE PERFORMANCE OF THE FIRST SEMESTER OF THE YEAR (606.06 KB)
Financial Data
Download

16/07/24 - 8:31

Diasorin receives FDA de-novo grant for the SIMPLEXA® C. auris Direct assay on the LIAISON® MDX instrument (546.76 KB)
Products Molecular
Download

05/06/24 - 5:07

Diasorin receives FDA 510(k) clearance for the LIAISON PLEX® Blood Culture Yeast Assay on the new multiplexing LIAISON PLEX® (693.98 KB)
Products Molecular
Download

16/05/24 - 19:56

Diasorin receives FDA 510(k) clearance for the updated syndromic panel NxTAG® Respiratory Pathogen Panel v2 (500.66 KB)
Products Molecular
Download

10/05/24 - 15:21

Q1 Revenues and Adjusted EBITDA in line with the high range of the FY’24 Guidance (689.42 KB)
Financial Data
Download

24/04/24 - 15:38

Shareholders' Meeting 2024 (159.72 KB)
Other
Download

16/04/24 - 8:20

Communication on total amount of voting rights (135.47 KB)
Other
Download

15/03/24 - 13:35

The Board of Directors of Diasorin SpA approves FY2023 Results; proposed ordinary dividend of € 1.15 per share (401.32 KB)
Financial Data
Download

13/03/24 - 10:23

Diasorin submits LIAISON PLEX® Yeast Blood Culture Assay for the LIAISON PLEX® system to the U.S. FDA (530.89 KB)
Products Molecular
Download

03/03/24 - 19:32

Diasorin receives FDA 510(K) clearance for its LIAISON PLEX® system together with the LIAISON PLEX® Respiratory Panel (150.83 KB)
Products Molecular
Download

25/01/24 - 7:48

Diasorin announces that it submitted the LIAISON® LymeDetect® to the U.S. Food and Drug Administration in December 2023 (507.38 KB)
Products Immunodiagnostic
Download

21/12/18 - 11:30

DiaSorin launches 3 new primer pairs for use in molecular testing (438.25 KB)
Products Molecular
Download

04/12/18 - 8:00

DiaSorin's stocks listed in the FTSE MIB (464.63 KB)
Financial Data
Download

19/11/18 - 15:00

DiaSorin launches Simplexa Group B Strep Direct molecular assay in the United States (435.43 KB)
Products Molecular
Download

07/11/18 - 13:00

DiaSorin Group reports growth in revenues and net profit in the first nine months of 2018 (961.72 KB)
Financial Data
Download

17/10/18 - 11:51

DiaSorin launches Simplexa Group B Strep Direct molecular assay in the european market (147.78 KB)
Products Molecular
Download

12/10/18 - 11:47

DiaSorin launches Simplexa VZV Direct molecular assay in the european market (444.81 KB)
Products Molecular
Download

09/10/18 - 11:35

DiaSorin and Meridian enter into a strategic collaboration to sell Helicobacter pylori stool antigen test in the United States and in the United Kingdom (471.21 KB)
Acquisition / Partnership
Download

17/09/18 - 11:28

DiaSorin launches the new LIASON quantiFERON-TB Gold Plus assay as an aid for latent tuberculosis detection in partnership with Qiagen (753.85 KB)
Products Immunodiagnostic
Download

07/08/18 - 8:45

Communication on total amount of voting rights (305.24 KB)
Financial Data
Download

02/08/18 - 12:45

The Board of Directors approves the results for the first half of 2018 (883.1 KB)
Financial Data
Download

27/07/18 - 12:00

DiaSorin launches Hepatitis Delta (HDV) test on LIAISON XL platform (735.03 KB)
Products Immunodiagnostic
Download

03/07/18 - 18:30

Conclusion treasury shares buy-back plan (397.33 KB)
Financial Data
Download

03/07/18 - 18:30

Annex 3F (treasury shares buy back July 2018) (6.59 KB)
Financial Data
Download

03/07/18 - 18:30

Report treasury shares buy-back (287.99 KB)
Financial Data
Download

03/07/18 - 18:30

Annex 3F (treasury shares buy back June 2018) (8.69 KB)
Financial Data
Download

29/06/18 - 18:15

Weekly report treasury shares buy-back (290.62 KB)
Financial Data
Download

22/06/18 - 20:30

Weekly report treasury shares buy-back (290.6 KB)
Financial Data
Download

15/06/18 - 21:00

Weekly report treasury shares buy-back (290.62 KB)
Financial Data
Download

12/06/18 - 14:15

DiaSorin introduces primer pair reagents for use in molecular testing: Anaplasma phagocytophilum, Ehrlichia e Babesia (445.17 KB)
Products Molecular
Download

08/06/18 - 23:15

Weekly report treasury shares buy-back (290.24 KB)
Financial Data
Download

04/06/18 - 13:15

Annex 3F (treasury shares buy back May 2018) (8.54 KB)
Financial Data
Download

01/06/18 - 20:15

Weekly report treasury shares buy-back (290.38 KB)
Financial Data
Download

25/05/18 - 22:30

Weekly report treasury shares buy-back (289.97 KB)
Financial Data
Download

19/05/18 - 1:45

Weekly report treasury shares buy-back (289.76 KB)
Financial Data
Download

11/05/18 - 20:15

Weekly report treasury shares buy-back (290.77 KB)
Financial Data
Download

08/05/18 - 14:30

The DiaSorin Group reports growth in revenues and profitability in the first quarter 2018 (832.84 KB)
Financial Data
Download

03/05/18 - 20:15

Start up treasury shares buy-back plan (354.27 KB)
Financial Data
Download

24/04/18 - 14:00

Annex 3F (treasury shares buy back) (7.77 KB)
Financial Data
Download

23/04/18 - 18:30

Annual General Meeting 2018 (589.65 KB)
Financial Data
Download

19/04/18 - 21:15

Conclusion treasury shares buy-back plan (397.59 KB)
Financial Data
Download

19/04/18 - 21:00

Weekly report treasury shares buy-back (289.29 KB)
Financial Data
Download

13/04/18 - 20:30

Weekly report treasury shares buy-back (290.07 KB)
Financial Data
Download

06/04/18 - 19:45

Weekly report treasury shares buy-back (288.33 KB)
Financial Data
Download

05/04/18 - 12:00

DiaSorin receives FDA clearance for the LIAISON BRAHMS PCT II GEN assay to detect severe bacterial infections (e.g. Sepsis) (737.88 KB)
Products Immunodiagnostic
Download

04/04/18 - 20:00

Start up treasury shares buy-back plan (346.04 KB)
Financial Data
Download

28/03/18 - 18:45

DiaSorin earns FDA clearence extending sample claims for Simplexa HSV 1 & 2 direct molecular test (442.69 KB)
Products Molecular
Download

07/03/18 - 15:30

DiaSorin: FY 2017 Results (1.14 MB)
Financial Data
Download

30/01/18 - 11:45

DiaSorin signs an agreement with the Italian Tax Authority granting tax relief under the Italian Patent Box regime (574.68 KB)
Financial Data
Download

08/01/18 - 9:00

QIAGEN and DiaSorin partner to offer fully automated tuberculosis detection with QuantiFERON-TB Gold Plus available on LIAISON analyzer systems (483.2 KB)
Acquisition / Partnership
Download

08/01/18 - 9:00

QIAGEN and DiaSorin partner to offer fully automated tuberculosis detection with QuantiFERON-TB Gold Plus available on LIAISON analyzer systems (483.2 KB)
Acquisition / Partnership
Download
Price Sensitive

eMarket SDIR System and eMarket STORAGE
For the dissemination and the storage of Regulated Information, DiaSorin S.p.A. uses the eMarket SDIR circuit and the eMarket STORAGE mechanism (available at the address www.emarketstorage.it), managed by Teleborsa S.r.l., with registered office in Piazza di Priscilla, 4, Rome, Italy.